–
Rapport Therapeutics, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
millions USD
FY23:
FY24:
–
FY25:
–
(positive)
Change from FY23 to FY25
millions USD
FY23:
−36.2
FY24:
−83.1
FY25:
−125
(positive)
Change from FY23 to FY25
millions USD
FY23:
−33.5
FY24:
−82.2
FY25:
−124
(positive)
Change from FY23 to FY25
millions USD
FY23:
−34.8
FY24:
−78.3
FY25:
−111
(positive)
Change from FY23 to FY25
millions USD
FY23:
−34.8
FY24:
−78.3
FY25:
−111
All amounts in millions USD